Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 23Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 109Neoplasms 108Lung Neoplasms 66Prostatic Neoplasms 57Colorectal Neoplasms 48Carcinoma, Non-Small-Cell Lung 44Pancreatic Neoplasms 31Hematologic Neoplasms 28Multiple Myeloma 23Leukemia, Myeloid, Acute 23Stomach Neoplasms 21Ovarian Neoplasms 21Carcinoma, Hepatocellular 21Brain Neoplasms 21Lymphoma 20Melanoma 19Esophageal Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Disease 18Urinary Bladder Neoplasms 17Colonic Neoplasms 16Uterine Cervical Neoplasms 15Liver Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Head and Neck Neoplasms 14Endometrial Neoplasms 14Lymphoma, Non-Hodgkin 13Leukemia 13Kidney Neoplasms 13Carcinoma, Renal Cell 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Adenocarcinoma Of Esophagus × 30 days × Clear all
NCT07212491 2026-05-06

Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma

Mayo Clinic

Enrolling by invitation
450 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡